We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marsh & McLennan's (MMC) Unit Divests Atlas to Stoch Analytics
Read MoreHide Full Article
Marsh & McLennan Companies, Inc.’s (MMC - Free Report) business, Oliver Wyman, recently announced the acquisition of its Atlas Software business by Stoch Analytics. Stoch Analytics Limited is a newly formed private firm and was earlier a business of Oliver Wyman.
Oliver Wyman Actuarial Consulting and Oliver Wyman will continue their partnership with Stoch Analytics in the future, further benefiting from its expertise. Atlas is a modeling platform based on the cloud used by companies in the Life insurance space for carrying out valuation, pricing, and asset liability management. Regulatory changes for Life and Retirement insurers will further foster the growth of analytical solutions.
This move bodes well for MMC’s Oliver Wyman, as it will be able to serve clients better with the help of Stoch Analytics. Stoch Analytics will be able to focus more on the development and delivery of risk management and actuarial solutions. Lately, the demand for performing complex modeling has increased for life insurers. Hence, to be able to serve this gap in the market bodes well for MMC. Atlas, being one of the most efficient and fast modeling platforms, should help insurers in decreasing their cloud expenditure and augmenting their actuarial and financial resources.
Stoch Analytics’ solutions will now include the Atlas software solutions and iReplicate policyholder compression tool, helping shorten the model runtime by 90% or more. Oliver Wyman is a faster-growing business for MMC. It expects business to register growth in mid-to-high-single digits over the long term. We expect Oliver Wyman’s revenues to grow at a three-year CAGR of 7.9% by 2025.
Price Performance
Shares of Marsh & McLennan have soared 15.9% in the past year compared with the industry’s 11.3% rise.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Marsh & McLennan currently has a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Assurant’s current-year earnings indicates a 30.8% year-over-year increase. It beat earnings estimates in all the past four quarters, with an average surprise of 42.4%. Also, the consensus mark for AIZ’s 2023 revenues suggests 5.4% year-over-year growth.
The Zacks Consensus Estimate for Brown & Brown’s current-year earnings is pegged at $2.76 per share, which indicates 21.1% year-over-year growth. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 12.3%. Also, the consensus mark for BRO’s 2023 revenues suggests 17.9% year-over-year growth.
The consensus mark for Arthur J. Gallagher’s current-year earnings indicates a 13.4% year-over-year increase. It beat earnings estimates in all the past four quarters, with an average surprise of 2.2%. Furthermore, the consensus estimate for AJG’s 2023 revenues suggests 18.2% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Marsh & McLennan's (MMC) Unit Divests Atlas to Stoch Analytics
Marsh & McLennan Companies, Inc.’s (MMC - Free Report) business, Oliver Wyman, recently announced the acquisition of its Atlas Software business by Stoch Analytics. Stoch Analytics Limited is a newly formed private firm and was earlier a business of Oliver Wyman.
Oliver Wyman Actuarial Consulting and Oliver Wyman will continue their partnership with Stoch Analytics in the future, further benefiting from its expertise. Atlas is a modeling platform based on the cloud used by companies in the Life insurance space for carrying out valuation, pricing, and asset liability management. Regulatory changes for Life and Retirement insurers will further foster the growth of analytical solutions.
This move bodes well for MMC’s Oliver Wyman, as it will be able to serve clients better with the help of Stoch Analytics. Stoch Analytics will be able to focus more on the development and delivery of risk management and actuarial solutions. Lately, the demand for performing complex modeling has increased for life insurers. Hence, to be able to serve this gap in the market bodes well for MMC. Atlas, being one of the most efficient and fast modeling platforms, should help insurers in decreasing their cloud expenditure and augmenting their actuarial and financial resources.
Stoch Analytics’ solutions will now include the Atlas software solutions and iReplicate policyholder compression tool, helping shorten the model runtime by 90% or more. Oliver Wyman is a faster-growing business for MMC. It expects business to register growth in mid-to-high-single digits over the long term. We expect Oliver Wyman’s revenues to grow at a three-year CAGR of 7.9% by 2025.
Price Performance
Shares of Marsh & McLennan have soared 15.9% in the past year compared with the industry’s 11.3% rise.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Marsh & McLennan currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Finance space are Assurant, Inc. (AIZ - Free Report) , Brown & Brown, Inc. (BRO - Free Report) and Arthur J. Gallagher & Co. (AJG - Free Report) . While Assurant currently sports a Zacks Rank #1 (Strong Buy), Brown & Brown and Arthur J. Gallagher carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Assurant’s current-year earnings indicates a 30.8% year-over-year increase. It beat earnings estimates in all the past four quarters, with an average surprise of 42.4%. Also, the consensus mark for AIZ’s 2023 revenues suggests 5.4% year-over-year growth.
The Zacks Consensus Estimate for Brown & Brown’s current-year earnings is pegged at $2.76 per share, which indicates 21.1% year-over-year growth. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 12.3%. Also, the consensus mark for BRO’s 2023 revenues suggests 17.9% year-over-year growth.
The consensus mark for Arthur J. Gallagher’s current-year earnings indicates a 13.4% year-over-year increase. It beat earnings estimates in all the past four quarters, with an average surprise of 2.2%. Furthermore, the consensus estimate for AJG’s 2023 revenues suggests 18.2% year-over-year growth.